Clinical Features and Treatment Outcomes of 51 Patients with Chronic Myeloid Leukemia Treated with a Tyrosine Kinase Inhibitor at a Single Institution from 2002 to 2014

Although clinical trials of first- and second-generation tyrosine kinase inhibitors (TKIs) have been shown to improve the prognosis of chronic myeloid leukemia (CML), there is still uncertainty about the clinical features, treatment outcomes, adverse effects, and other possible problems of their use...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Exp Hematop
Κύριοι συγγραφείς: Kawano, Noriaki, Yoshida, Shuro, Kawano, Sayaka, Kuriyama, Takuro, Yamashita, Kiyoshi, Ochiai, Hidenobu, Shimoda, Kazuya, Ishikawa, Fumihiko, Ueda, Akira, Kikuchi, Ikuo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: JSLRT 2016
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144279/
https://ncbi.nlm.nih.gov/pubmed/27334856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.34
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια